Jazz Pharmaceuticals
JAZZ
#2088
Rank
A$11.77 B
Marketcap
$194.77
Share price
1.25%
Change (1 day)
5.29%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$2.00

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.17. In 2022 the company made an earnings per share (EPS) of -$5.44 an increase over its 2021 EPS that were of -$8.27.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.00-63.18%
2022-$5.44-34.2%
2021-$8.27-224.83%
2020$6.63-53.25%
2019$14.1823.59%
2018$11.47-8.24%
2017$12.5023.74%
2016$10.1022.12%
2015$8.27478.49%
2014$1.43-74.93%
2013$5.70-27.11%
2012$7.8369.1%
2011$4.63245.98%
2010$1.34-462.5%
2009-$0.37-96.7%
2008-$11.19-27.04%
2007-$15.3465.47%
2006-$9.27-4.59%
2005-$9.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.18 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$12.75-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.75-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$3.08 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel